Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
The anticancer activity of the combination therapy of gemcitabine and doxorubicin encapsulated in a nanoemulsion
النشاط المضاد للسرطان لمزيج علاج الجيمسيتابين والدوكسوروبيسين المغلف في مستحلب نانومتري
Subject
:
Faculty of Sciences > Biochemistry department
Document Language
:
Arabic
Abstract
:
Doxorubicin (DOX) is a chemotherapeutic drug used for treatment of a wide variety of cancers. It is known to cause cardiotoxicity. Gemcitabine (GEM) is an anticancer drug, but it has certain limitations like short biological half-life. A new paradigm to improve DOX and GEM therapeutic index is to administer them in nanoparticles (NPs). Nanoemulsions (NEs) are well-characterized NPs drug carriers that have been broadly implemented in the delivery of anticancer therapeutics. In this study, the antitumor activity of the combination formulas of GEM and DOX, either loaded in water (GEM+DOX-Sol) or NEs (GEM+DOX/LNE), were evaluated in Ehrlich ascites carcinoma (EAC) bearing swiss albino mice. The anticancer assessment of the NEs formulas in 200 mice divided into 10 groups included the detection of the change in body weight, hematological and serum biochemical profiles and studying the histopathological alterations of the heart, liver and kidney tissues. Results showed that mice treated with GEM+DOX/LNE which has z-average 155.38 nm and zeta potential -38.5 mV, recorded a decrease in the mean tumor weight and significant increase in the cumulative mean survival time (MST), which was 60 days, as compared to the EAC control group, which has MST of 28 days. It also showed no significant changes in hematological and serum biochemical profiles compared to the normal group. In conclusion, the present study suggested that GEM treatment may significantly reduce cardiotoxicity induced by DOX in EAC-bearing mice. Also, GEM enhances the antitumor properties of DOX by increasing its inhibitory effect on tumor growth.
Supervisor
:
Prof. Mayson Husni Alkhatib
Thesis Type
:
Master Thesis
Publishing Year
:
1437 AH
2016 AD
Co-Supervisor
:
Prof. Faiza Baker Abdo
Added Date
:
Sunday, April 17, 2016
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
وفاء سعيد الشهري
Alshehri, Wafaa Saeed
Researcher
Master
Files
File Name
Type
Description
38588.pdf
pdf
Back To Researches Page